Regency Therapeutics, a division of Luitpold Pharmaceuticals, Inc., markets innovative pharmaceutical products that offer meaningful alternatives to patients and those that care for them. Currently focused on the treatment of acute pain, we seek to provide fiscally and socially responsible solutions to challenging problems facing our customers and our health care system.